Frequently asked questions on COVID-19 vaccination

COVID-19 vaccination for cancer patients

A fifth wave of COVID-19 is now spreading across the globe, with high rates in cancer patients. As the immune system is weakened by cancer, COVID-19 can more easily break through the immune system and cause infection in the human body. Therefore, the US Centers for Disease Control (CDC), American Society of Clinical Oncology (ASCO), European Society of Oncology (ESMO) and American Cancer Society (ACS) all recommend that cancer patients should be vaccinated against COVID-19 as soon as possible.

Currently, there are two COVID-19 vaccines provided by the Hong Kong government. The first uses an inactivated version of the SARS-CoV-2 virus and is known as the Sinovac vaccine; the second uses messenger RNA (mRNA), called the BioNTech vaccine.

Both vaccines have been approved by the Hong Kong Food and Health Bureau as safe and effective vaccines to reduce the risk of severe illness from contracting COVID-19.

In the video below, Icon Cancer Centre Hong Kong Medical Oncologist Dr. Thomas Yau uses different international clinical studies to deconstruct information about vaccination of cancer patients and answer frequently asked questions.


Making an appointment

Find out how to make an appointment at Icon Cancer Centre, or request more information from your nearest centre.
Learn more

Care team

Every member of Icon’s team is here to help. Here are some of the team members you may meet and who will be involved in your treatment.
Learn more

Our doctors

Icon brings together an experienced team of clinical oncologists dedicated to supporting patients throughout their treatment.
Learn more